Skip to main content
Journal cover image

Comparison of survival of stage I-III colon cancer by travel distance and hospital volume.

Publication ,  Journal Article
Turner, MC; Jawitz, O; Adam, MA; Srinivasan, E; Niedzwiecki, D; Migaly, J; Fisher, DA; Mantyh, CR
Published in: Tech Coloproctol
July 2020

BACKGROUND: Previous studies have demonstrated improved outcomes at high-volume colorectal surgery centers; however, the benefit for patients who live far from such centers has not been assessed relative to local, low-volume facilities. METHODS: The 2010-2015 National Cancer Database (NCDB) was queried for patients with stage I-III colon adenocarcinoma undergoing treatment at a single center. A 'local, low-volume' cohort was constructed of 12,768 patients in the bottom quartile of travel distance at the bottom quartile of institution surgical volume and a 'travel, high-volume' cohort of 11,349 patients in the top quartile of travel distance at the top quartile of institution surgical volume. RESULTS: In unadjusted analysis, patients in the travel cohort had improved rates of positive resection margins (3.7% vs. 5.5%, p < 0.001), adequate lymph-node harvests (92% vs. 83.6%, p < 0.001), and 30- (2.2% vs. 3.9%, p < 0.001) and 90-day mortality (3.7% vs. 6.4%, p < 0.001). On multivariable logistic regression analysis adjusting for patient demographic, tumor, and facility characteristics, the cohorts demonstrated equivalent overall survival (HR: 0.972, p = 0.39), with improved secondary outcomes in the 'travel' cohort of adequate lymph-node harvesting (OR: 0.57, p < 0.001), and 30- (OR 0.79, p = 0.019) and 90-day mortality (OR 0.80, p = 0.004). CONCLUSIONS: For patients with stage I-III colon cancer, traveling to high-volume institutions compared to local, low-volume centers does not convey an overall survival benefit. However, given advantages including 30- and 90-day mortality and adequate lymph-node harvest, nuanced patient recommendations should consider both these differences and the unquantified benefits to local care, including cost, travel time, and support systems.

Duke Scholars

Altmetric Attention Stats
Dimensions Citation Stats

Published In

Tech Coloproctol

DOI

EISSN

1128-045X

Publication Date

July 2020

Volume

24

Issue

7

Start / End Page

703 / 710

Location

Italy

Related Subject Headings

  • Treatment Outcome
  • Travel
  • Survival Rate
  • Surgery
  • Retrospective Studies
  • Neoplasm Staging
  • Humans
  • Hospitals, Low-Volume
  • Hospitals, High-Volume
  • Colonic Neoplasms
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Turner, M. C., Jawitz, O., Adam, M. A., Srinivasan, E., Niedzwiecki, D., Migaly, J., … Mantyh, C. R. (2020). Comparison of survival of stage I-III colon cancer by travel distance and hospital volume. Tech Coloproctol, 24(7), 703–710. https://doi.org/10.1007/s10151-020-02207-8
Turner, M. C., O. Jawitz, M. A. Adam, E. Srinivasan, D. Niedzwiecki, J. Migaly, D. A. Fisher, and C. R. Mantyh. “Comparison of survival of stage I-III colon cancer by travel distance and hospital volume.Tech Coloproctol 24, no. 7 (July 2020): 703–10. https://doi.org/10.1007/s10151-020-02207-8.
Turner MC, Jawitz O, Adam MA, Srinivasan E, Niedzwiecki D, Migaly J, et al. Comparison of survival of stage I-III colon cancer by travel distance and hospital volume. Tech Coloproctol. 2020 Jul;24(7):703–10.
Turner, M. C., et al. “Comparison of survival of stage I-III colon cancer by travel distance and hospital volume.Tech Coloproctol, vol. 24, no. 7, July 2020, pp. 703–10. Pubmed, doi:10.1007/s10151-020-02207-8.
Turner MC, Jawitz O, Adam MA, Srinivasan E, Niedzwiecki D, Migaly J, Fisher DA, Mantyh CR. Comparison of survival of stage I-III colon cancer by travel distance and hospital volume. Tech Coloproctol. 2020 Jul;24(7):703–710.
Journal cover image

Published In

Tech Coloproctol

DOI

EISSN

1128-045X

Publication Date

July 2020

Volume

24

Issue

7

Start / End Page

703 / 710

Location

Italy

Related Subject Headings

  • Treatment Outcome
  • Travel
  • Survival Rate
  • Surgery
  • Retrospective Studies
  • Neoplasm Staging
  • Humans
  • Hospitals, Low-Volume
  • Hospitals, High-Volume
  • Colonic Neoplasms